BRIDGING GAPS IN IMMUNOTHERAPIES / IMMUNE EFFECTOR CELL THERAPIES AND AUTO-IMMUNITY

October 10, 2026

The Pediatric Transplant and Cellular Therapy (PTCT) program will host a symposium entitled " Bridging Gaps in Immunotherapies/Immune Effector Cell Therapies and Auto-Immunity" at Duke University Medical Center, Durham, North Carolina, on October 10th,2026. Aims: Enclosed you will find a tentative conference agenda that aims to bring pediatric multi and inter-disciplinary learners from across the globe via a hybrid in-person and online platform, to (i) discuss current state and future landscape for immunotherapies and immune effector cell therapies for autoimmune diseases. (ii) review toxicities associated with immunotherapies and immune effector cell therapies for autoimmune diseases. (iii)discuss macrophage activating syndrome (MAS) and management as a model for understanding expected toxicities in treating autoimmune diseases. (iv) develop a white-paper strategy regarding candidate selection for immunotherapies and immune effector cell therapies for autoimmune diseases and management of expected toxicities.

This course is open for anyone to attend, please use the link below to register for the course…

SIGN IN - Bridging Gaps in Immunotherapies/Immune Effector Cell Therapies and Auto-Immunity

 


 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Pharmacists

Learning Objectives

Presentations will include PowerPoint lectures, Q&A sessions, and case discussions tobridge the identified practice gap.

Participants will gain comprehensive education on:

(i)discuss current state and future landscape for immunotherapies and immune effector celltherapies for autoimmune diseases.

(ii) review toxicities associated with immunotherapiesand immune effector cell therapies for autoimmune diseases.

(iii) discuss macrophageactivating syndrome (MAS) and management as a model for understanding expectedtoxicities in treating autoimmune diseases.

(iv) develop a white-paper strategy regardingcandidate selection for immunotherapies and immune effector cell therapies for autoimmunediseases and management of expected toxicities.

Course summary

Available credit: 
  • 6.00 ACPE - Pharmacist
  • 6.00 AMA PRA Category 1 Credit(s)™
  • 6.00 ANCC
  • 6.00 Attendance
Registration Opens: 
10/10/2026
Registration Expires: 
12/10/2026
Activity Starts: 
10/10/2026 - 8:30am EDT
Activity Ends: 
10/10/2026 - 5:00pm EDT
Add to calendar: 
Rating: 
0
  • Bradley S. Marino, MD
  • Dr. Kris Mahadeo
  • Dr. Chenyu Lin
  • Dr. Susan Canny
  • Dr. Andrew Yee
  • Dr. Juliana Silva
  • Dr. Bhavani Murugesan
  • Dr. David McCall
  • Dr. Vanderson Rocha
  • Dr. Tara Streich-Tilles
  • Dr. Joseph Oved
  • Dr. Dristhi Ragoonanan
  • Dr. Hisham Abdel-Azim
  • Dr. Yike Jiang
  • Jacob Keller
  • LaTarsha Spencer
  • Dr. Shelby Reed
  • Dr. Juan Marcos Gonzalez Sepulveda

 

 

 

 

  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance

 

Available Credit

  • 6.00 ACPE - Pharmacist
  • 6.00 AMA PRA Category 1 Credit(s)™
  • 6.00 ANCC
  • 6.00 Attendance
Please login or register to take this course.